**Core Concept**
Radiation proctitis is a complication of pelvic radiation therapy characterized by inflammation and damage to the rectal mucosa. The underlying pathophysiology involves damage to the microvasculature and subsequent ischemia, leading to symptoms such as bleeding, pain, and diarrhea.

**Why the Correct Answer is Right**
Sucralfate is a mucosal protective agent that forms a protective barrier on the surface of the gastrointestinal mucosa, protecting it from further injury and promoting healing. It works by binding to the exposed collagen and mucin, thereby protecting the mucosa from further radiation damage. This mechanism is particularly useful in radiation proctitis, where the mucosa is already compromised.

**Why Each Wrong Option is Incorrect**
**Option A:** Corticosteroids may worsen radiation proctitis by increasing the risk of bleeding and perforation. They are not a first-line treatment for this condition.
**Option B:** Metronidazole is an antibiotic that may be used to treat infections associated with radiation proctitis, but it does not address the underlying mucosal damage.
**Option C:** Loperamide is an antidiarrheal medication that may be used to control symptoms of radiation proctitis, but it does not promote healing or protection of the mucosa.

**Clinical Pearl / High-Yield Fact**
Sucralfate is also used to treat other conditions such as peptic ulcers and gastroesophageal reflux disease (GERD), where mucosal protection is beneficial.

**Correct Answer: C. Sucralfate**